Humacyte, Inc. Lessee, Operating Lease, Liability, to be Paid
Humacyte, Inc. (HUMA) had Lessee, Operating Lease, Liability, to be Paid of $784.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-03-31
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $784.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $889.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $994.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $1.10M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-12-31 | $784.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | $889.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $994.00K 10-K · filed 2023-03-24 |
| 2021-12-31 | $1.10M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |